Want to see HK:9955 full AI Analyst Report?
9955 Stock Chart & Stats
HK$1.00
HK$0.03(2.52%)
At close: 4:00 PM EST
HK$1.00
HK$0.03(2.52%)
Day’s Range― - ―
52-Week RangeHK$0.46 - HK$1.80
Previous CloseN/A
Volume146.50K
Average Volume (3M)1.09M
Market Cap
HK$315.28M
Enterprise ValueHK$332.69M
Total Cash (Recent Filing)HK$410.55M
Total Debt (Recent Filing)HK$288.63M
Price to Earnings (P/E)―
Beta1.82
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding645,718,800
10 Day Avg. Volume899,970
30 Day Avg. Volume1,090,236
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.00
Price to Sales (P/S)0.34
P/FCF Ratio-8.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)HK$7.73B
Bulls Say, Bears Say
Bulls Say
Balance Sheet NormalizationPositive equity and a moderate, improving debt-to-equity provide durable financial stability versus earlier negative-equity years. This reduces short-term insolvency risk, preserves access to supplier and lender financing, and gives management room to execute restructuring or growth initiatives over months.
Material Gross Margin ImprovementA sustained ~48% gross margin marks structural improvement in procurement, pricing or product mix, which supports profitability as scale recovers. Higher gross margins increase the likelihood that incremental revenue contributes to operating profits and provide a buffer against cost pressures.
Operating Cash Flow Turned PositiveA return to positive operating cash flow indicates the core retail operations can generate cash, improving liquidity and reducing dependence on financing. If sustained, positive OCF enables reinvestment in stores and supply chain and supports a path to consistent free-cash-flow generation.
Bears Say
Sharp Revenue ContractionA ~30% revenue decline reverses prior growth, weakening scale and retail network productivity. Sustained top-line contraction can erode supplier terms, reduce operating leverage, and make it difficult to cover fixed costs, threatening medium-term recovery prospects.
Large Net Losses RemainDeep net losses and a ~-57% net margin materially erode retained capital and limit the firm’s ability to self-fund growth. Persistent bottom-line losses increase refinancing risk, constrain strategic flexibility, and require sustained margin and revenue improvement to restore profitability.
Negative Free Cash FlowNegative free cash flow shows operations plus investments still drain cash, necessitating external funding or asset sales to cover cash shortfalls. This constrains capital allocation, increases dependency on creditors, and raises execution risk for strategic initiatives over the coming months.
ClouDr Group Limited News
9955 FAQ
What was ClouDr Group Limited’s price range in the past 12 months?
ClouDr Group Limited lowest stock price was HK$0.46 and its highest was HK$1.80 in the past 12 months.
What is ClouDr Group Limited’s market cap?
ClouDr Group Limited’s market cap is HK$315.28M.
When is ClouDr Group Limited’s upcoming earnings report date?
ClouDr Group Limited’s upcoming earnings report date is Aug 14, 2026 which is in 12 days.
How were ClouDr Group Limited’s earnings last quarter?
ClouDr Group Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.636 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.636.
Is ClouDr Group Limited overvalued?
According to Wall Street analysts ClouDr Group Limited’s price is currently Overvalued.
Does ClouDr Group Limited pay dividends?
ClouDr Group Limited does not currently pay dividends.
What is ClouDr Group Limited’s EPS estimate?
ClouDr Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ClouDr Group Limited have?
ClouDr Group Limited has 645,718,800 shares outstanding.
What happened to ClouDr Group Limited’s price movement after its last earnings report?
ClouDr Group Limited reported an EPS of -HK$0.636 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.154%.
Which hedge fund is a major shareholder of ClouDr Group Limited?
Currently, no hedge funds are holding shares in HK:9955
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ClouDr Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-38.03%
Trailing 12-Months
Company Description
ClouDr Group Limited
ClouDr Group Limited operates as an investment holding company, providing a diverse range of services within the healthcare sector. The firm supplies hospitals and pharmacies with crucial medical products, including devices like blood glucose meters and vital sign monitors, glucose testing strips, and both over-the-counter and prescription drugs. In addition to physical goods, ClouDr delivers software-as-a-service (SaaS) platforms tailored for healthcare facilities and pharmacies, while also offering digital marketing solutions to pharmaceutical companies. Furthermore, the company facilitates the management of chronic conditions through real-time online consultations, digital health monitoring, and remote prescription and ordering services. Established in 2014, ClouDr Group Limited maintains its primary corporate office in Hangzhou, China.
Technical Analysis
China Health Group
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―